Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Nelson L. Michael
Nelson L. Michael, MD, PhD is the Director of the US Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR), an international HIV vaccine research program that successfully integrates HIV/AIDS prevention, care and treatment. MHRP operates its main laboratory in Silver Spring, Maryland with additional administrative activities in Bethesda, Maryland, USA. MHRP partners with affiliates in five African nations and Thailand to execute a broad portfolio of translational and clinical research in areas with high burdens of HIV/AIDS. Dr Michael, a Colonel in the United States Army Medical Corps, entered his Army service in 1989 in WRAIR's Department of Vaccine Research, Division of Retrovirology, and later served as the Chief, Department of Molecular Diagnostics and Pathogenesis. Dr Michael was appointed Director of MHRP in January 2006, and guided MHRP through the completion of the RV144 HIV prime-boost vaccine study. This clinical trial, an international collaboration that involved more than 16,000 Thai volunteers, provided the world's first demonstration that a preventive HIV vaccine was possible. Dr Michael's research interests include HIV molecular pathogenesis and host genetics, HIV clinical research, and HIV vaccine development. He is a Professor of Medicine, Uniformed Services University and is a Diplomat, American Board of Internal Medicine. He serves as a peer reviewer of many scientific journals and is author/coauthor of more than 190 scientific publications, and eight textbooks. Honors include the Army Commendation Medal (1992, 1996), the Army Achievement Medal (1996), and the Army Meritorious Service Medal (2004, 2010). Dr Michael was recently elected to the Association of American Physicians (2013) and was the 2013 Army recipient of the Heroes of Military Medicine Award. Dr Michael currently serves on President Obama's Presidential Commission for the Study of Bioethical Issues, the Vaccine Research Center Scientific Advisory Working Group (NIAID, NIH), Office of AIDS Research Advisory Committee (NIH), AIDS Research Advisory Committee (NIAID, NIH), AIDS Vaccine Research Working Group (DAIDS, NIAID, and NIH), Center for HIV/AIDS Vaccine Immunology Scientific Advisory Board, Office of the Global AIDS Coordinator Scientific Steering Committee, the Scientific Committee of the Global HIV AIDS Vaccine Enterprise and the PEPFAR Scientific Advisory Board. Dr Michael graduated summa cum laude from University of California, Los Angeles, USA, in 1979 with a degree in biology and from Stanford University, USA, with MD and PhD (cancer biology) degrees in 1986. He trained in internal medicine at Harvard Medical School, Massachusetts General Hospital, USA, from 1986 to 1989.
Glenda Gray, MBBCH, FCPaeds (SA), is the Executive Director of the Perinatal HIV Research Unit and Research Professor based at the University of the Witwatersrand, South Africa. She is the Co-PI of the HIV Vaccine Trials Network and Director of HVTN International Programs. She has expertise in the field of mother to child transmission of HIV; adolescent HIV prevention and treatment; and HIV vaccine and microbicide research. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1. She is a member of the Academy of Science in South Africa, and chairs their standing committee on health and has served on two expert panels for the Academy. She is a Foreign Associate of the Institute of Medicine, of the National Academies, and is on the IOM's Global Health Board. Trained as a medical doctor and later specialised in the area of Paediatrics, she co-founded the PHRU, based in Soweto at the Chris Hani Baragwanath Hospital. This research unit is world renowned for clinical research, epidemiology, operational research and treatment site for HIV infected adults and children, employing 300 individuals. She was responsible for overseeing the first HIV vaccine trials that were run in-country, and was the Chair of HVTN 503/Phambili. She spearheaded the clinical development of the South African AIDS Vaccine initiative's HIV vaccines, the SAAVI DNA/MVA candidates and Chaired HVTN 073/073e, the first in human studies of these vaccines.
Glenda Gray has also been awarded the IAPAC Hero of Medicine award for work done in the field of HIV treatment in children and adults. In 2009, James McIntyre and Glenda Gray received the N’Galy-Mann lectureship in recognition of their HIV research contribution in South Africa. In June 2012 she received a Doctor of Science, honoris causa from the Simon Fraser University, Vancouver, Canada. She has also been admitted into the American Academy of Microbiology in 2012. In 2013 she was awarded the country's highest honour, the Order of Mapungubwe, an award granted by the president of South Africa for achievements in the international area which have served South Africa's interest.
Lynne M. Mofenson
Lynne Mofenson, MD, is a pediatric infectious disease specialist and Chief of the Maternal and Pediatric Infectious Disease Branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development in Bethesda, Maryland, USA. Her clinical research has focused management of pediatric and maternal HIV infection and prevention of mother-to-child HIV transmission. She received her medical degree from Albert Einstein College of Medicine, USA, with honors in 1977, followed by a residency in pediatrics at Boston Children's Hospital, Boston, Massachusetts, USA, and a pediatric chief residency and joint adult/pediatric infectious disease fellowship at the University of Massachusetts Medical School, Worcester, Massachusetts, USA. Following several years in private practice of infectious diseases and pediatrics, she joined the Massachusetts Department of Public Health as Assistant Commissioner for Division of Communicable Disease Control in 1985. She was responsible for all communicable disease programs for the Massachusetts Department of Public Health, including the newly formed HIV/AIDS program, where she was involved in setting up the first HIV testing program in the state, policy development related to pediatric and maternal HIV infection, and delineating the epidemiology of HIV in Massachusetts.
In 1989, she came to the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, in Bethesda, Maryland, as Associate Branch Chief for Clinical Research in the Pediatric, Adolescent and Maternal AIDS Branch (now called the Maternal and Pediatric Infectious Disease Branch); she has been Branch Chief since 2002. Dr Mofenson is responsible for program planning and the development and scientific direction of research studies and clinical trials in domestic and international pediatric, adolescent and maternal HIV infection, disease and AIDS. She has published and lectured extensively on issues related to perinatal HIV transmission and prevention as well as treatment of pediatric HIV infection, and has been involved in clinical trials of HIV treatment in children and women and prevention mother-to-child HIV transmission in the United States and internationally since 1990. She has authored over 270 peer-reviewed publications and 31 textbook chapters. She serves as the Executive Secretary of the Public Health Task Force that develops national recommendations on use of antiretroviral drugs in HIV-infected pregnant women for reducing perinatal HIV transmission and treatment of maternal HIV disease and for the Pediatric Antiretroviral Guidelines Panel that develops guidelines for treatment of HIV infection in children in the USA. She also serves as a consultant to international organizations such as the World Health Organization on policies related to prevention of mother-to-child HIV transmission and antiretroviral treatment of HIV-infected children and women, and was most recently involved in the 2013 revision of the World Health Organization treatment guidelines for HIV-infected pregnant women and children.
She is a fellow of the American Academy of Pediatrics, American Pediatric Society, and Infectious Disease Society of America, and member of the editorial boards for the Journal of Acquired Immune Deficiency Syndrome, PLosMedicine, and AIDS, and Section Editor on HIV in pregnancy for Up-to-Date. She has been the recipient of numerous awards, including Public Health Service Special Recognition Award, Department of Health and Human Services Award for Distinguished Service, NIH World AIDS Day Award, Albert Einstein College of Medicine Alumni Lifetime Achievement Award, and most recently the Samuel J Heyman Service to America 2012 Federal Employee of the Year Medal and the N’galy-Mann Lectureship.